Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $55.39 USD
Change Today -0.32 / -0.57%
Volume 772.6K
CPHD On Other Exchanges
As of 4:30 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Bishop

Chairman, Chief Executive Officer and Member of Equity Incentive Committee, Cepheid
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John L. Bishop has been the Chief Executive Officer of Cepheid since April 2002. Mr. Bishop joined Cepheid in 2002. He served as President and Chief Executive Officer of Vysis, Inc. Mr. Bishop served as the President of Abbott Molecular Inc. from November 1993 to 2002 and served as Chief Executive Officer from February 1996 to March 2002. Mr. Bishop served as the Chairman of the Board and Chief Executive Officer of MicroProbe Corp. from 1991 to November 1993 and ...

Read Full Background

Corporate Headquarters*

904 Caribbean Drive
Sunnyvale, California 94089

United States

Phone: 408-541-4191
Fax: 408-541-4192

Board Members Memberships*

Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Director and Member of Compensation Committee


University of Miami

Other Affiliations*

Annual Compensation*

Total Annual Compensation$664,908

Stock Options*

Restricted Stock Awards$893,880
All Other Compensation$14,285
Exercised Options400,000
Exercised Options Value$15,504,184
Exercisable Options750,936
Exercisable Options Value$21,968,686
Unexercisable Options345,314
Unexercisable Options Value$4,338,214
Total Value of Options$41,811,084
Total Number of Options1,496,250

Total Compensation*

Total Annual Cash Compensation$1,238,633
Total Short Term Compensation$664,908
Other Long Term Compensation$908,165
Total Calculated Compensation$4,841,669
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPHD:US $55.39 USD -0.32


Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
John A. Krauetler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
Carlo Rosa Chief Executive Officer, General Manager and Executive Director
DiaSorin S.p.A.
Jong-Yoon Cheon Founder, Chief Executive Officer and Chief Technology Officer
Seegene, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEPHEID INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at